Good morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stock futures rose on Tuesday. There’s some indication China might be loosening COVID restrictions, as Beijing recently pledged to bolster vaccination among its senior citizens, a move considered crucial to ending harsh lockdowns.

Another catalyst for the rise could be the likelihood the Federal Reserve will move to a slower rate-hiking pace. We’ll know more Wednesday when Fed Chairman Jerome Powell speaks.

The market has been volatile in 2022, which is why our Head Fundamental Tactician Karim Rahemtulla is putting his focus on value stocks. He’s high on one particular company that could be set up to withstand any headwinds. And there’s an upcoming announcement in December that could send it soaring.

Click here to unlock this $2 stock.

Here’s a look at the top-moving stocks this morning.

NanoVibronix (Nasdaq: NAOV)

NanoVibronix is up 19.96% premarket after the medical device company announced FDA 510(k) clearance of its PainShield™ MD PLUS, a dual-actuator ultrasound pain therapy device. This is the next step in achieving permanent clearance and full-scale commercial viability.

Kala Pharmaceuticals (Nasdaq: KALA)

Kala Pharmaceuticals is up 18.66% premarket after announcing up to $31 million in private placement financing. The eye care company entered into a definitive agreement with a life sciences-focused investor for a sale. Under the terms of the agreement, Kala will sell 76,813 shares of common stock at a price of $5.75 per share and an aggregate of 9,666 shares of its Series E Preferred at a price of $575 per share.

Medical breakthroughs often result in some of the highest gains for stocks. Right now our friend Alexander Green has his eye on a medical device company he believes will ‘save millions of lives in the U.S.’ SpaceX CEO Elon Musk recently sent this device into orbit and Inc. magazine says the company behind this development will ‘change healthcare forever.’

Click here to unlock this $3 medical stock.

The AZEK Company, Inc. (NYSE: AZEK)

The AZEK Company is down 8.10% premarket after missing on earnings. The environmentally sustainable outdoor product company came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. The report represents an earnings surprise of -5.88%.

The Chemours Company (NYSE: CC)

The Chemours Company is down 6.17% premarket after the chemicals company says it’s on pace to miss guidance. It’s currently running slightly below the low end of its full-year 2022 guidance range, with an adjusted EBITDA between $1.40 billion and $1.45 billion. Free cash flow came in at more than $575 million. Overall, a weaker demand for titanium dioxide, ‘most notably in Europe and Asia as the global outlook grows increasingly uncertain’ is the main reason for the drop, according to the company.

While many stocks are struggling in 2022, it’s important to consider hard assets like gold. Gold has been considered an inflation safe-haven for a long time – but you have to know how to invest correctly.

Click here to learn the correct way to invest in hard assets.

Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team